Why We Oppose Golden Rice
By The Stop Golden Rice Network,
Independent Science News
| 08. 07. 2020
Released on the 7th annual International Day of Protest Against Golden Rice
The push for corporate-led solutions to hunger and malnutrition is alarming. In particular, Golden Rice is now being proposed as a solution to the worsening hunger and malnutrition associated with the pandemic. Agrochemical transnationals (TNCs) and collaborating institutions such as the International Rice Research Institute (IRRI) are using concerns over food security during the pandemic to push for an industrial agricultural system that is already discredited. To quote PAN Asia Pacific:
“in the webinar “The future of food systems in Southeast Asia post-COVID19” organised by IRRI and the FAO, Jean Balie, IRRI’s head of Agri-Food Policy, said that they are “looking to increase the mineral and vitamin content in rice grains” as a response to the pandemic, alluding to renewed promotion of the genetically-modified Golden Rice, which has recently been approved for commercialization in Bangladesh and the Philippines” said PANAP.
Golden Rice projects and applications are currently underway in three countries. On December 10, 2019, the Philippines’ Dept. of Agriculture’s Bureau of Plant Industry (DA-BPI) issued a Golden Rice permit for Direct Use for Food, Feed and...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...